Related Experiment Video
Updated: Sep 10, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Efficacy of a teaching kitchen program for patients with type 2 diabetes in Japan: protocol for an open-label
Megu Y Baden1,2, Saki Kawamoto3, Takuya Kagisaki3
1Department of Metabolic Medicine, Graduate School of Medicine, The University of Osaka, Suita, Osaka, Japan mbaden@endmet.med.osaka-u.ac.jp.
Introduction:
This open-label randomised controlled trial (Teaching Kitchen for Diabetes in Japan [TKD-J] trial) evaluates the effectiveness of a modified Teaching Kitchen program for Japanese patients with type 2 diabetes. Based on the US Teaching Kitchen Multisite Trial, this program integrates hands-on culinary instruction with evidence-based lectures on nutrition, physical activity, sleep and mindfulness, combined with a personalised approach. This is the first prospective study to assess its impact on glycaemic control and clinical, behavioural, quality-of-life outcomes among Japanese patients with type 2 diabetes.
Methods And Analysis:
Two hundred adults aged 20-79 years with type 2 diabetes (HbA1c 6.5-8.9%) and either body mass index ≥23 kg/m² or abdominal obesity (waist ≥85 cm for men or ≥90 cm for women) will be recruited from Osaka University Hospital and 16 affiliated medical institutions in Japan. Participants will be randomly assigned in a 1:1 ratio to either an initial-start or a delayed intervention group (starting after a 4-month delay). The 12-month intervention includes a 4-month main program (weekly) and 8-month maintenance program (monthly), followed by a 4-month post-intervention follow-up. Data will be collected at baseline, and at months 0, 4, 8, 12 and 16. In the initial start group, the baseline and month 0 assessments coincide. In the delayed intervention group, month 0 occurs 4 months after baseline, following a control period. The primary outcome is the change in HbA1c levels during the first 4-month period, which corresponds to the randomised controlled trial phase. Secondary outcomes are changes in fasting plasma glucose, glycaemic variability assessed by blinded continuous glucose monitoring, diabetes treatment, anthropometric and metabolic measures, dietary behaviour, physical activity, sleep, quality of life, mindfulness, cooking skills and self-efficacy. In addition, program satisfaction and records collected through web application will also be assessed. Between-group and within-group changes over time will be analysed using mixed-effects linear regression models.
Ethics And Dissemination:
The study has been approved by the Ethics Committee of Osaka University Hospital (approval number: 23179 [T2]). Written informed consent will be obtained from all participants. Findings will be disseminated through peer-reviewed journals, conference presentations and community outreach.
Trial Registration Number:
UMIN-CTR (UMIN000052514).
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
05:06Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...